Efficacy and safety of capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated pancreatic, gallbladder, and bile duct carcinoma

被引:0
作者
Jens Kruth
Johanna Nissen
Thomas Ernst
Melanie Kripp
Nadine Lukan
Kirsten Merx
Wolf-Karsten Hofmann
Andreas Hochhaus
Ralf-Dieter Hofheinz
机构
[1] Universitätsmedizin Mannheim,III. Medizinische Klinik, Hämatologie und Onkologie
[2] Ruprecht-Karls-Universität Heidelberg,Institut für Klinische Radiologie und Nuklearmedizin
[3] Universitätsmedizin Mannheim,Abteilung Hämatologie/Onkologie, Klinik für Innere Medizin II
[4] Universität Heidelberg,undefined
[5] Universitätsklinikum Jena,undefined
来源
Journal of Cancer Research and Clinical Oncology | 2010年 / 136卷
关键词
Bile duct carcinoma; Capecitabine; Docetaxel; Gallbladder carcinoma; Mitomycin C; Pancreatic carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1845 / 1851
页数:6
相关论文
共 258 条
[1]  
Barreto Miranda M(2008)Phase II study of mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer: interim analysis of a multicenter trial Onkologie 31 159-194
[2]  
Hartmann JT(2005)Weekly docetaxel in combination with capecitabine in patients with metastatic gastric cancer Am J Clin Oncol 28 188-902
[3]  
Al-Batran SE(2007)Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials Br J Cancer 96 896-1479
[4]  
Hochhaus A(2007)Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial Br J Cancer 97 1475-745
[5]  
Hofheinz R-D(2006)Phase II trial evaluating a docetaxel-capecitabine combination as treatment for hormone-refractory prostate cancer Cancer 107 738-11
[6]  
Chun JH(2009)The role of capecitabine in the management of tumors of the digestive system Rev Recent Clin Trials 4 1-656
[7]  
Kim HK(2006)Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group Ann Oncol 17 652-1924
[8]  
Lee JS(2003)A phase II study of weekly docetaxel plus capecitabine for patients with advanced nonsmall cell lung carcinoma Cancer 98 1918-517
[9]  
Choi JY(2001)Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma Ann Surg 234 507-481
[10]  
Hwangbo B(1958)Non-parametric estimation from incomplete observations J Am Stat Assoc 53 457-1876